LEXINGTON, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the 10th Annual BIO Investor Forum at 4:30 p.m. PDT (7:30 EDT) on Tuesday, October 25, 2011, in San Francisco, CA.
